Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

256 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Impact of histological variants on oncological outcomes of patients with urothelial carcinoma of the bladder treated with radical cystectomy.
Xylinas E, Rink M, Robinson BD, Lotan Y, Babjuk M, Brisuda A, Green DA, Kluth LA, Pycha A, Fradet Y, Faison T, Lee RK, Karakiewicz PI, Zerbib M, Scherr DS, Shariat SF. Xylinas E, et al. Among authors: babjuk m. Eur J Cancer. 2013 May;49(8):1889-97. doi: 10.1016/j.ejca.2013.02.001. Epub 2013 Mar 4. Eur J Cancer. 2013. PMID: 23466126
Obesity is associated with worse oncological outcomes in patients treated with radical cystectomy.
Chromecki TF, Cha EK, Fajkovic H, Rink M, Ehdaie B, Svatek RS, Karakiewicz PI, Lotan Y, Tilki D, Bastian PJ, Daneshmand S, Kassouf W, Durand M, Novara G, Fritsche HM, Burger M, Izawa JI, Brisuda A, Babjuk M, Pummer K, Shariat SF. Chromecki TF, et al. Among authors: babjuk m. BJU Int. 2013 Feb;111(2):249-55. doi: 10.1111/j.1464-410X.2012.11322.x. Epub 2012 Jun 21. BJU Int. 2013. PMID: 22727036
Pathologic nodal staging score for bladder cancer: a decision tool for adjuvant therapy after radical cystectomy.
Shariat SF, Rink M, Ehdaie B, Xylinas E, Babjuk M, Merseburger AS, Svatek RS, Cha EK, Tagawa ST, Fajkovic H, Novara G, Karakiewicz PI, Trinh QD, Daneshmand S, Lotan Y, Kassouf W, Fritsche HM, Chun FK, Sonpavde G, Joual A, Scherr DS, Gonen M. Shariat SF, et al. Among authors: babjuk m. Eur Urol. 2013 Feb;63(2):371-8. doi: 10.1016/j.eururo.2012.06.008. Epub 2012 Jun 16. Eur Urol. 2013. PMID: 22727174
Impact of smoking on oncologic outcomes of upper tract urothelial carcinoma after radical nephroureterectomy.
Rink M, Xylinas E, Margulis V, Cha EK, Ehdaie B, Raman JD, Chun FK, Matsumoto K, Lotan Y, Furberg H, Babjuk M, Pycha A, Wood CG, Karakiewicz PI, Fisch M, Scherr DS, Shariat SF; Upper Tract Urothelial Carcinoma Collaboration. Rink M, et al. Among authors: babjuk m. Eur Urol. 2013 Jun;63(6):1082-90. doi: 10.1016/j.eururo.2012.06.029. Epub 2012 Jun 22. Eur Urol. 2013. PMID: 22743166 Free PMC article.
Predictors of survival in patients with soft tissue surgical margin involvement at radical cystectomy.
Xylinas E, Rink M, Novara G, Green DA, Clozel T, Fritsche HM, Guillonneau B, Lotan Y, Kassouf W, Tilki D, Babjuk M, Karakiewicz PI, Montorsi F, Abdennabi J, Trinh QD, Svatek RS, Scherr DS, Zerbib M, Shariat SF. Xylinas E, et al. Among authors: babjuk m. Ann Surg Oncol. 2013 Mar;20(3):1027-34. doi: 10.1245/s10434-012-2708-5. Epub 2012 Oct 26. Ann Surg Oncol. 2013. PMID: 23099729
Long-term cancer-specific outcomes of TaG1 urothelial carcinoma of the bladder.
Rieken M, Xylinas E, Kluth L, Crivelli JJ, Chrystal J, Faison T, Lotan Y, Karakiewicz PI, Holmäng S, Babjuk M, Fajkovic H, Seitz C, Klatte T, Pycha A, Bachmann A, Scherr DS, Shariat SF. Rieken M, et al. Among authors: babjuk m. Eur Urol. 2014 Jan;65(1):201-9. doi: 10.1016/j.eururo.2013.08.034. Epub 2013 Aug 27. Eur Urol. 2014. PMID: 23998688
Effect of diabetes mellitus and metformin use on oncologic outcomes of patients treated with radical cystectomy for urothelial carcinoma.
Rieken M, Xylinas E, Kluth L, Crivelli JJ, Chrystal J, Faison T, Lotan Y, Karakiewicz PI, Sun M, Fajkovic H, Babjuk M, Bachmann A, Scherr DS, Shariat SF. Rieken M, et al. Among authors: babjuk m. Urol Oncol. 2014 Jan;32(1):49.e7-14. doi: 10.1016/j.urolonc.2013.07.006. Epub 2013 Oct 17. Urol Oncol. 2014. PMID: 24140245
Prognostic factors and risk groups in T1G3 non-muscle-invasive bladder cancer patients initially treated with Bacillus Calmette-Guérin: results of a retrospective multicenter study of 2451 patients.
Gontero P, Sylvester R, Pisano F, Joniau S, Vander Eeckt K, Serretta V, Larré S, Di Stasi S, Van Rhijn B, Witjes AJ, Grotenhuis AJ, Kiemeney LA, Colombo R, Briganti A, Babjuk M, Malmström PU, Oderda M, Irani J, Malats N, Baniel J, Mano R, Cai T, Cha EK, Ardelt P, Varkarakis J, Bartoletti R, Spahn M, Johansson R, Frea B, Soukup V, Xylinas E, Dalbagni G, Karnes RJ, Shariat SF, Palou J. Gontero P, et al. Among authors: babjuk m. Eur Urol. 2015 Jan;67(1):74-82. doi: 10.1016/j.eururo.2014.06.040. Epub 2014 Jul 16. Eur Urol. 2015. PMID: 25043942 Free article.
256 results